However, they are still oral medications subject to the effects of delayed gastric emptying
Make it a part of your weekly routine Besides setting phone reminders or calendar alerts, Dr
Based on REDEFINE trial populations and the NDA submission terms, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition such as hypertension, dyslipidemia, type 2 diabetes, or obstructive sleep apnea Adults 18 years or older Not pregnant or breastfeeding Contraindications will likely include: personal or family history of MTC or MEN 2 syndrome, prior serious allergic reaction to semaglutide or cagrilintide, and active pancreatitis
Many patients either restart treatment later or switch to other weight management options, which may help limit weight gain
[6] [5] Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
Dehydration can lead to hard, dry stools that are difficult to pass, increasing the likelihood of straining and rectal bleeding
